Aurora Cannabis Inc.
Aurora Cannabis Inc. (ACB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
acb · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Aurora Cannabis Inc. (ACB) measures how much investors pay for each dollar of the company's trailing earnings. ACB's current PE ratio of N/A is calculated by dividing its stock price of $3.41 by its TTM earnings per share of -$0.75.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%217.8x
MedianQ3 · 75%1467.9x
Max
At N/A, ACB's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Aurora Cannabis Inc.You ACB | $202M | N/A | — | -$0.75 |
 Aclaris Therapeutics, Inc. ACRS | $526M | N/A | — | -$0.53 |
 BioAge Labs, Inc. BIOA | $584M | N/A | — | -$2.24 |
 Canopy Growth Corporation CGC | $434M | N/A | — | -$5.56 |
 Editas Medicine, Inc. EDIT | $259M | N/A | — | -$1.80 |
 High Tide Inc. HITI | $204M | N/A | — | -$0.62 |
 Ironwood Pharmaceuticals, Inc. IRWD | $542M | 22.76x | — | $0.15 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | 217.84x | $0.03 | — | |
2024-03-31 FY2024 | — | $-1.35 | — | |
2023-03-31 FY2023 | — | $-25.30 | — | |
2022-06-30 FY2022 | — | $-79.92 | — | |
2021-06-30 FY2021 | — | $-40.92 | — | |
2020-06-30 FY2020 | — | $-333.92 | — | |
2019-06-30 FY2019 | — | $-36.65 | — | |
2018-06-30 FY2018 | 61.97x | $18.00 | — | |
2017-06-30 FY2017 | — | $-6.00 | — | |
2016-06-30 FY2016 | — | $-5.32 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Aurora Cannabis Inc. (ACB) measures how much investors pay for each dollar of the company's trailing earnings. ACB's current PE ratio of N/A is calculated by dividing its stock price of $3.41 by its TTM earnings per share of -$0.75.
Frequently asked questions
ACB pe ratio · 6 questionsACB's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.41 and TTM EPS of -$0.75. Data sourced from Financial Modeling Prep via ACB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aurora Cannabis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08